Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study led by Professor Jonathan Rees, NDORMS will look into the benefits of shoulder surgery following first time traumatic dislocation of the shoulder compared to non-operative treatments such as physiotherapy in preventing further problems.

Professor Rees says: "We are delighted to have won this commissioned award from the HTA and look forward to answering this important UK shoulder healthcare question. The results of this study will provide very useful evidence and information to doctors treating this condition and to patients suffering with it."

Traumatic anterior shoulder dislocations are the most common form of joint dislocations seen in hospital A+E departments however there is still debate on the best treatment to take after the first incident.

In this form of dislocation, the humeral head (top end of the arm bone at the shoulder) is forced out of the shoulder socket frontwards. This can happen after sport injuries or falls and is most common in younger patients. The injury is very painful and the shoulder often stays dislocated until it is reduced or put back in hospital.

In addition to causing a lot of pain, stress and disability, this type of injury often causes the joint to remain unstable and more dislocations can occur. Due to the risk of further dislocations, surgery has become more common as a treatment, but it is still not known which patients are best treated with physiotherapy and which patients are best treated first with surgery.

The UK TASH-D (Treatment of first-time traumatic Anterior SHoulder Dislocation) team will be using information that is already available within the NHS on young patients aged 16-35 years who suffer with traumatic shoulder dislocations to determine whether shoulder surgery is better than non-operative treatments.

The study will also identify risk factors for re-dislocation such as occupation or sport that may influence the type of treatment.

UK TASH-D is funded by the NIHR Health Technology Assessment programme, with HTA Project Reference 14/160/01.

UK_TASH-D

Similar stories

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.